To conclude, in the current chordoma series, we found no tumor cell PD-L1 expression, but we did find a negative prognostic role for PD-L1+ immune cells, supporting the need for further studies in this field and the notion of a possible beneficial role of immunotherapy in these patients. Here, CD274 is linked to chordoma.